Washington Research Foundation has pledged $10 million over five years in support of a new program led by UW Medicine’s Brotman Baty Institute (BBI) and the Allen Institute.
The program, called SeaBridge, will advance cell and genome reprogramming technologies developed at the Seattle Hub for Synthetic Biology, a collaboration among BBI, the Allen Institute and the Chan Zuckerberg Initiative. The grant is among the largest in the foundation’s 44-year history.
The funding will enable SeaBridge to train a new generation of scientists, leverage the region’s expertise in cell therapy, and launch startups to drive advanced treatment options for neurological and immune disorders and a variety of cancers.
Jay Shendure, MD, PhD, BBI scientific director and professor of genome sciences at the UW School of Medicine, leads Seattle Hub. Along with Shendure, the SeaBridge program will be led by Seattle Hub Co-Director Marion Pepper, PhD, chair of the UW School of Medicine Department of Immunology, and Jesse Gray, PhD, Seattle Hub senior director for strategy and platform at the Allen Institute.
Read the full announcement from the UW Medicine Newsroom.
